SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.

MLA

Mazzoni, Alessio, et al. “SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.” Frontiers in Immunology, vol. 13, Jan. 2022, pp. 1–8. EBSCOhost, https://doi.org/10.3389/fimmu.2022.801431.

APA

Mazzoni, A., Vanni, A., Spinicci, M., Capone, M., Lamacchia, G., Salvati, L., Coppi, M., Antonelli, A., Carnasciali, A., Farahvachi, P., Giovacchini, N., Aiezza, N., Malentacchi, F., Zammarchi, L., Liotta, F., Rossolini, G. M., Bartoloni, A., Cosmi, L., Maggi, L., & Annunziato, F. (2022). SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron. Frontiers in Immunology, 13, 1–8. https://doi.org/10.3389/fimmu.2022.801431

Chicago

Mazzoni, Alessio, Anna Vanni, Michele Spinicci, Manuela Capone, Giulia Lamacchia, Lorenzo Salvati, Marco Coppi, et al. 2022. “SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.” Frontiers in Immunology 13 (January): 1–8. doi:10.3389/fimmu.2022.801431.